Short Interest in Ultralife Co. (NASDAQ:ULBI) Drops By 18.1%

Ultralife Co. (NASDAQ:ULBI - Get Free Report) saw a significant decline in short interest in March. As of March 31st, there was short interest totalling 105,600 shares, a decline of 18.1% from the March 15th total of 128,900 shares. Based on an average trading volume of 62,100 shares, the short-interest ratio is currently 1.7 days. Approximately 1.1% of the company's stock are sold short.

Institutional Investors Weigh In On Ultralife

A number of institutional investors have recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Ultralife during the 3rd quarter valued at approximately $36,000. Citigroup Inc. bought a new position in shares of Ultralife during the 3rd quarter valued at approximately $74,000. Victory Capital Management Inc. bought a new position in shares of Ultralife during the 4th quarter valued at approximately $59,000. Virtu Financial LLC bought a new position in shares of Ultralife during the 4th quarter valued at approximately $72,000. Finally, Algert Global LLC bought a new position in shares of Ultralife during the 3rd quarter valued at approximately $106,000. 30.68% of the stock is owned by institutional investors.

Ultralife Stock Up 0.7 %

ULBI stock traded up $0.06 during trading on Friday, reaching $8.96. The stock had a trading volume of 32,292 shares, compared to its average volume of 60,469. Ultralife has a one year low of $3.92 and a one year high of $11.85. The company has a quick ratio of 2.02, a current ratio of 3.80 and a debt-to-equity ratio of 0.19. The company's 50 day moving average is $8.91 and its two-hundred day moving average is $8.27. The company has a market capitalization of $147.39 million, a price-to-earnings ratio of 20.36 and a beta of 1.26.

Ultralife (NASDAQ:ULBI - Get Free Report) last issued its quarterly earnings data on Thursday, February 15th. The technology company reported $0.18 earnings per share (EPS) for the quarter. Ultralife had a net margin of 4.54% and a return on equity of 7.36%. The business had revenue of $44.55 million during the quarter.

Analyst Ratings Changes

Several research firms have recently commented on ULBI. StockNews.com downgraded shares of Ultralife from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, March 26th. Benchmark upped their price objective on shares of Ultralife from $12.00 to $13.00 and gave the stock a "buy" rating in a research report on Tuesday, March 5th.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.